A randomized, double-blind, placebo-controlled study to determine the safety and immune effects of multiple doses of vitamin D3 in patients with allergic rhinitis/rhino-conjunctivitis caused by birch pollen and in healthy control subjects.

Trial Profile

A randomized, double-blind, placebo-controlled study to determine the safety and immune effects of multiple doses of vitamin D3 in patients with allergic rhinitis/rhino-conjunctivitis caused by birch pollen and in healthy control subjects.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2015

At a glance

  • Drugs Paricalcitol (Primary)
  • Indications Allergic rhinitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top